| Product Code: ETC13244898 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Arthritis Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Arthritis Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Arthritis Market Revenues & Volume, 2021 & 2031F |
3.3 North America Arthritis Market - Industry Life Cycle |
3.4 North America Arthritis Market - Porter's Five Forces |
3.5 North America Arthritis Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Arthritis Market Revenues & Volume Share, By Rheumatoid Drug Type, 2021 & 2031F |
3.7 North America Arthritis Market Revenues & Volume Share, By Rheumatoid Treatment, 2021 & 2031F |
3.8 North America Arthritis Market Revenues & Volume Share, By Rheumatoid Diagnosis, 2021 & 2031F |
3.9 North America Arthritis Market Revenues & Volume Share, By Osteoarthritis Type, 2021 & 2031F |
3.10 North America Arthritis Market Revenues & Volume Share, By Osteoarthritis Diagnosis, 2021 & 2031F |
3.11 North America Arthritis Market Revenues & Volume Share, By Osteoarthritis Treatment, 2021 & 2031F |
3.12 North America Arthritis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.12 North America Arthritis Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 North America Arthritis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Arthritis Market Trends |
6 North America Arthritis Market, 2021 - 2031 |
6.1 North America Arthritis Market, Revenues & Volume, By Rheumatoid Drug Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Arthritis Market, Revenues & Volume, By Biologics, 2021 - 2031 |
6.1.3 North America Arthritis Market, Revenues & Volume, By Non-Biologics, 2021 - 2031 |
6.1.4 North America Arthritis Market, Revenues & Volume, By Steroids, 2021 - 2031 |
6.1.5 North America Arthritis Market, Revenues & Volume, By Analgesics, 2021 - 2031 |
6.1.6 North America Arthritis Market, Revenues & Volume, By Glucocorticoids, 2021 - 2031 |
6.1.7 North America Arthritis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 North America Arthritis Market, Revenues & Volume, By Rheumatoid Treatment, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Arthritis Market, Revenues & Volume, By Synovectomy, 2021 - 2031 |
6.2.3 North America Arthritis Market, Revenues & Volume, By Tendon Repair, 2021 - 2031 |
6.2.4 North America Arthritis Market, Revenues & Volume, By Joint Fusion, 2021 - 2031 |
6.2.5 North America Arthritis Market, Revenues & Volume, By Symptomatic Treatment, 2021 - 2031 |
6.2.6 North America Arthritis Market, Revenues & Volume, By Intermediate Corticosteroid Therapies, 2021 - 2031 |
6.2.7 North America Arthritis Market, Revenues & Volume, By DMARD Therapies, 2021 - 2031 |
6.3 North America Arthritis Market, Revenues & Volume, By Rheumatoid Diagnosis, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Arthritis Market, Revenues & Volume, By C.R.P. Test, 2021 - 2031 |
6.3.3 North America Arthritis Market, Revenues & Volume, By C.C.P., 2021 - 2031 |
6.3.4 North America Arthritis Market, Revenues & Volume, By E.S.R. Test, 2021 - 2031 |
6.4 North America Arthritis Market, Revenues & Volume, By Osteoarthritis Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America Arthritis Market, Revenues & Volume, By Hip, 2021 - 2031 |
6.4.3 North America Arthritis Market, Revenues & Volume, By Spinal, 2021 - 2031 |
6.4.4 North America Arthritis Market, Revenues & Volume, By Knee, 2021 - 2031 |
6.4.5 North America Arthritis Market, Revenues & Volume, By Foot and Ankle, 2021 - 2031 |
6.4.6 North America Arthritis Market, Revenues & Volume, By Shoulder, 2021 - 2031 |
6.4.7 North America Arthritis Market, Revenues & Volume, By Hand, 2021 - 2031 |
6.5 North America Arthritis Market, Revenues & Volume, By Osteoarthritis Diagnosis, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Arthritis Market, Revenues & Volume, By Imaging, 2021 - 2031 |
6.5.3 North America Arthritis Market, Revenues & Volume, By Joint Fluid Analysis, 2021 - 2031 |
6.5.4 North America Arthritis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 North America Arthritis Market, Revenues & Volume, By Osteoarthritis Treatment, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America Arthritis Market, Revenues & Volume, By Medication, 2021 - 2031 |
6.6.3 North America Arthritis Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.6.4 North America Arthritis Market, Revenues & Volume, By Assistive Devices, 2021 - 2031 |
6.6.5 North America Arthritis Market, Revenues & Volume, By Surgery, 2021 - 2031 |
6.6.6 North America Arthritis Market, Revenues & Volume, By Therapy, 2021 - 2031 |
6.7 North America Arthritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 North America Arthritis Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.7.3 North America Arthritis Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.8 North America Arthritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.8.1 Overview & Analysis |
6.8.2 North America Arthritis Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.8.3 North America Arthritis Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.8.4 North America Arthritis Market, Revenues & Volume, By Household, 2021 - 2031 |
6.8.5 North America Arthritis Market, Revenues & Volume, By Medical Institutes, 2021 - 2031 |
6.8.6 North America Arthritis Market, Revenues & Volume, By Research Organizations, 2021 - 2031 |
6.8.7 North America Arthritis Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Arthritis Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Arthritis Market, Revenues & Volume, By Rheumatoid Drug Type, 2021 - 2031 |
7.2.1 United States (US) Arthritis Market, Revenues & Volume, By Rheumatoid Drug Type, 2021 - 2031 |
7.2.2 Canada Arthritis Market, Revenues & Volume, By Rheumatoid Drug Type, 2021 - 2031 |
7.2.3 Rest of North America Arthritis Market, Revenues & Volume, By Rheumatoid Drug Type, 2021 - 2031 |
7.3 North America Arthritis Market Revenues & Volume Share, By Rheumatoid Treatment, 2021 & 2031F |
7.3.1 United States (US) Arthritis Market, Revenues & Volume, By Rheumatoid Treatment, 2021 - 2031 |
7.3.2 Canada Arthritis Market, Revenues & Volume, By Rheumatoid Treatment, 2021 - 2031 |
7.3.3 Rest of North America Arthritis Market, Revenues & Volume, By Rheumatoid Treatment, 2021 - 2031 |
7.4 North America Arthritis Market, Revenues & Volume, By Rheumatoid Diagnosis, 2021 - 2031 |
7.4.1 United States (US) Arthritis Market, Revenues & Volume, By Rheumatoid Diagnosis, 2021 - 2031 |
7.4.2 Canada Arthritis Market, Revenues & Volume, By Rheumatoid Diagnosis, 2021 - 2031 |
7.4.3 Rest of North America Arthritis Market, Revenues & Volume, By Rheumatoid Diagnosis, 2021 - 2031 |
7.5 North America Arthritis Market, Revenues & Volume, By Osteoarthritis Type, 2021 - 2031 |
7.5.1 United States (US) Arthritis Market, Revenues & Volume, By Osteoarthritis Type, 2021 - 2031 |
7.5.2 Canada Arthritis Market, Revenues & Volume, By Osteoarthritis Type, 2021 - 2031 |
7.5.3 Rest of North America Arthritis Market, Revenues & Volume, By Osteoarthritis Type, 2021 - 2031 |
7.6 North America Arthritis Market, Revenues & Volume, By Osteoarthritis Diagnosis, 2021 - 2031 |
7.6.1 United States (US) Arthritis Market, Revenues & Volume, By Osteoarthritis Diagnosis, 2021 - 2031 |
7.6.2 Canada Arthritis Market, Revenues & Volume, By Osteoarthritis Diagnosis, 2021 - 2031 |
7.6.3 Rest of North America Arthritis Market, Revenues & Volume, By Osteoarthritis Diagnosis, 2021 - 2031 |
7.7 North America Arthritis Market, Revenues & Volume, By Osteoarthritis Treatment, 2021 - 2031 |
7.7.1 United States (US) Arthritis Market, Revenues & Volume, By Osteoarthritis Treatment, 2021 - 2031 |
7.7.2 Canada Arthritis Market, Revenues & Volume, By Osteoarthritis Treatment, 2021 - 2031 |
7.7.3 Rest of North America Arthritis Market, Revenues & Volume, By Osteoarthritis Treatment, 2021 - 2031 |
7.8 North America Arthritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.8.1 United States (US) Arthritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.8.2 Canada Arthritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.8.3 Rest of North America Arthritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.9 North America Arthritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.9.1 United States (US) Arthritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.9.2 Canada Arthritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.9.3 Rest of North America Arthritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8 North America Arthritis Market Key Performance Indicators |
9 North America Arthritis Market - Export/Import By Countries Assessment |
10 North America Arthritis Market - Opportunity Assessment |
10.1 North America Arthritis Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Arthritis Market Opportunity Assessment, By Rheumatoid Drug Type, 2021 & 2031F |
10.3 North America Arthritis Market Opportunity Assessment, By Rheumatoid Treatment, 2021 & 2031F |
10.4 North America Arthritis Market Opportunity Assessment, By Rheumatoid Diagnosis, 2021 & 2031F |
10.5 North America Arthritis Market Opportunity Assessment, By Osteoarthritis Type, 2021 & 2031F |
10.6 North America Arthritis Market Opportunity Assessment, By Osteoarthritis Diagnosis, 2021 & 2031F |
10.7 North America Arthritis Market Opportunity Assessment, By Osteoarthritis Treatment, 2021 & 2031F |
10.8 North America Arthritis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.9 North America Arthritis Market Opportunity Assessment, By End-Users, 2021 & 2031F |
11 North America Arthritis Market - Competitive Landscape |
11.1 North America Arthritis Market Revenue Share, By Companies, 2022 |
11.2 North America Arthritis Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here